Back to previous section

Novo Nordisk calls EGM as boardroom rift triggers mass exits

Danish pharmaceutical giant Novo Nordisk said on Tuesday it will hold an extraordinary general meeting on 14 November to elect a new board after a boardroom dispute over strategy saw more than half of the board members hand in their notice.

  • Novo Nordisk AS
  • 21 October 2025 14:12:20
Novo Nordisk

Source: Sharecast

Following disagreements with the Novo Nordisk Foundation over future board composition, chairman Helge Lund, vice chairman Henrik Poulsen and five independent directors will not seek re-election.

Lund will be replaced by Lars Rebien Sorensen, a previous leader of the company who now heads up its largest shareholder.

The move comes as part of a wider shakeup at the Wegovy and Ozempic weight loss drugmaker, and comes hot on the heels of the departure of its chief executive officer following a slump in the shares.

"After discussions with the Novo Nordisk Foundation about the future composition of the board, it was not possible to reach a mutual agreement. The board proposed a renewal focused on adding selected new competencies while maintaining continuity, whereas the foundation's board sought a more comprehensive restructuring," said chairman Helge Lund.

"After careful consideration, and given the foundation's position and control over the majority of votes in Novo Nordisk, the board concluded that it is in the best interests of the company and its shareholders to call an extraordinary general meeting to elect new board members and provide clarity on Novo Nordisk's future governance."

As of 1410 BST, Novo Nordisk shares were down 1.47% at DKK 354.50 each.

Reporting by Iain Gilbert at Sharecast.com

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.